Ignite Creation Date:
2025-12-24 @ 6:39 PM
Ignite Modification Date:
2026-02-28 @ 9:05 PM
Study NCT ID:
NCT04054557
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-08-21
First Post:
2019-08-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence
Sponsor:
Thomas Jefferson University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Stage 0 Breast Cancer AJCC v6 and v7 | View |
| None | Stage I Breast Cancer AJCC v7 | View |
| None | Stage IA Breast Cancer AJCC v7 | View |
| None | Stage IB Breast Cancer AJCC v7 | View |
| None | Stage II Breast Cancer AJCC v6 and v7 | View |
| None | Stage IIA Breast Cancer AJCC v6 and v7 | View |
| None | Stage IIB Breast Cancer AJCC v6 and v7 | View |
| None | Stage IIIA Breast Cancer AJCC v7 | View |
| None | Stage IIIB Breast Cancer AJCC v7 | View |
| None | Stage IIIC Breast Cancer AJCC v7 | View |
| None | Stage III Breast Cancer AJCC v7 | View |
Keywords: